Milestone for gene-edited therapy for sickle cell disease
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has…
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has…
Companies in the cell and gene therapy space are struggling to raise investments amid adverse…
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
CRISPR Therapeutics and its US partner Vertex Pharmaceuticals have released the first clinical results for…
The US giant Vertex Pharmaceuticals is expanding an existing collaboration with the Swiss company CRISPR…
Genomics, a company using machine learning to analyze genetic data, is partnering with precision medicine…
CRISPR Therapeutics and Vertex Pharmaceuticals are taking action to start a first clinical trial with…
Galapagos has announced to kick off a Phase I trial with its novel Cystic Fibrosis…
After Galapagos and AbbVie expanded their collaboration on cystic fibrosis, Galapagos now announces the start…
Merck is diversifying its oncology portfolio with four new programs licensed from Vertex Pharmaceuticals, including…
Enterome, a leader in the European microbiome field, has struck a deal with US' Vertex…
CRIPSR's hype is not going down yet. CRIPSR/Cas9 or Cpf1 is a revolutionising gene editing…